ArticleBiomolecules2026
Direct Phasing of Protein Crystals with Continuous Iterative Projection Algorithms and Refined Envelope Reconstruction.
Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Direct methods provide a model-free approach to solving the crystallographic phase problem and deliver unbiased atomic structures. However, conventional iterative projection algorithms such as Hybrid Input-Output (HIO) face two critical challenges: discontinuous density modification at the protein-solvent boundary and inaccurate molecular envelope reconstruction that fails to account for trapped solvent, particularly in crystals with solvent content approaching the lower limits of direct phasing applicability. We introduced four continuous iterative projection algorithms, including our improved continuous version, which implements smooth density modification at protein-solvent interfaces. To address envelope inaccuracy, we developed a two-step refined reconstruction scheme using sequential large-radius and small-radius Gaussian filters to identify trapped solvent molecules within surface cavities and internal channels. This scheme enhances the performance of both continuous and classical algorithms, including HIO, the difference map, and our improved versions. Benchmarking on 28 protein structures (solvent contents 55-78%, resolutions 1.46-3.2 Å, reported R-factor less than 0.22) showed that the refined envelope scheme increased average success rates of continuous algorithms by 45.7% and classical algorithms by 60.5%. The performance of continuous algorithms and improved classical algorithms proved comparable to the well-established HIO algorithm, forming a top-tier group that exceeded other classical algorithms. Integrating a genetic algorithm co-evolution strategy further enhanced average success rates by approximately 2.5-fold and accelerated convergence through population-wide information sharing. Although the success rate correlates with solvent content, our strategy improved success probability at any given solvent level, extending the practical boundaries of direct methods. The high success rate enabled averaging of multiple independent solutions, which reduced mean phase error by approximately 6.83° and yielded atomic models with backbone root-mean-square deviation (RMSD) typically below 0.5 Å relative to structures reported in the Protein Data Bank (PDB). This work introduces novel algorithms, a refined envelope reconstruction methodology, and an effective optimization strategy with genetic algorithm evolution. The complete framework enhances the capability and reliability of direct methods for phasing protein crystals with limited solvent content and provides a toolkit for addressing challenging cases in structural biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.